DTx WEST 2022

Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.

Dr. Parks’ research focuses on self-help methods for increasing well-being via books and digital technology. She is Chief Scientist for tech startup Happify, which brings the cutting edge in research-based well-being interventions to large businesses, health plans, and consumers. Her research spans across the whole spectrum of wellness, from non-distressed consumers to stressed employees, sufferers of chronic health conditions, and individuals with depression and/or anxiety. She works to pioneer new methodology in the study of digital therapeutics, especially when it comes to outcomes assessment. Her work has been published in peer-reviewed journals, and in addition to editing three books, she is also an Associate Editor at the Journal of Positive Psychology.

Dr. Rosner is an Associate Professor of Medicine and an informaticist and digital health researcher in the Center for Clinical Informatics and Improvement Research (CLIIR).

Dr. Rosner holds a PhD in engineering from the University of Minnesota and spent a decade as a part time Hospitalist at Kaiser Permanente prior to joining UCSF.

Julia Strandberg serves as Chief Commercial Officer at Pear Therapeutics, responsible for crafting and implementing patient-, clinician-, and payer-centered strategies to accelerate the adoption of Prescription Digital Therapeutics (PDTs). She draws on extensive experience in developing and commercializing innovative medical technologies. From medical devices and RFID technologies, to consumer electronics, she has championed novel technologies and innovative business models to transform healthcare and advance the healthcare industry.

Prior to joining Pear, Julia served as Medtronic’s Vice President & General Manager for the Health Informatics & Monitoring division. She also has served as Vice President of Global Marketing for the Patient Monitoring franchise for Covidien. Julia joined Covidien in the Strategy & Portfolio group for Sleep Diagnostics and Therapy. She began her career at 3M Company, where she held multiple engineering and marketing positions in the Optical Systems and Track and Trace solutions division.

She earned her MBA from University of Minnesota, Carlson School of Management, and her undergraduate degree in Chemical Engineering at Purdue University.

Ryan is a healthcare executive that has extensive experience commercializing innovative HealthTech solutions.  He’s currently Vice President of Growth at Wellsheet, a company working with health systems across the US providing a cloud-based, predictive workflow designed for providers at the point of care that substantially improves productivity and reduces clinician burnout. He previously led the commercialization of the Podimetrics SmartMat for four years, a remote patient monitoring solution capable of detecting 97% of diabetic foot ulcers five weeks before clinical presentation.  During this time, Ryan secured contracts with multiple health systems and health plans, including a national roll-out with the Veterans Health Administration. Ryan holds an MBA from Rice University and a BS in Naval Architecture from Webb Institute. 

Cyndi Williams is founder and CEO of Quin, a digital therapeutic that uses game narrative theory to treat diabetes distress and improve diabetes outcomes. Before founding Quin she was a managing director at ThoughtWorks, a global $500M software company, heading up the UK business and the global software products division. She spent her early career as a software engineer at Sun Microsystems and has BSc in Chemical Engineering from Northwestern University.

Adam is Director of Clinical Operations at Curebase, overseeing all Curebase’s clinical trials, including digital therapeutics. Adam has a range of therapeutic and research experience. He began his career as a coordinator and transitioned into monitoring and project management roles of increasing responsibility within CROs, academia, and pharma.

Adam received a master’s in clinical research from George Washington University and is active in his professional community.